Clinical Trial Update: HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for an HIV attachment inhibitor intended to treat HIV-1 infections; results have been posted with completion in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Immunodeficiency Virus Infection

Drugs mentioned

• HIV attachment inhibitor

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2018-11-14